Springer Protocols: Abstract: Determination of mRNA Stability and Characterization of Proteins Interacting with Adrenergic Receptor mRNAs

Determination of mRNA Stability and Characterization of Proteins Interacting with Adrenergic Receptor mRNAs

By: Burns C. Blaxall², J. David Port^{2 3}

Abstract

Full Text

Download PDF (172K)

Modulation of gene expression at the level of mRNA stability has emerged as an important regulatory paradigm. Although several general models of eukaryotic mRNA decay have been described, the details of how mRNA decay occurs for G-protein-coupled receptors is minimally characterized. By contrast, considerable information is known about the regulation of proto-oncogene and cytokine/lymphokine mRNA stability (for review, see ref. 1).

Affiliation(s): (2) Department of Pharmacology, University of Colorado Health Sciences Center, Denver, CO
(3) Division of Cardiology, Department of Medicine, University of Colorado Health Sciences Center, Denver, CO

Book Title: Adrenergic Receptor Protocols

Series: Methods in Molecular Biology | Volume: 126 | Pub. Date: Nov-05-1999 | Page Range: 453-465 | DOI: 10.1385/1-59259-684-3:453

Subject: Neuroscience

References

Download References

1.	Ross, J. (1995) mRNA stability in mammalian cells. Microbiol. Rev. 59, 423–450.

2.	Dixon, R., Kobilka, B., Strader, C, Benovic, J., Dohlman, H., Frielle, T., et al. (1986) Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 321, 75–79.

3.	Hadcock, J. R. and Malbon, C. C. (1988) Down-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc. Natl. Acad. Sci. USA 85, 5021–5025.

4.	Hadcock, J. R., Wang, H-Y., and Malbon, C. C. (1989) Agonist-induced destabilization of β-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors. J. Biol. Chem. 264, 19,928–19,933.

5.	Danner, S., Frank, M., and Lohse, M. J. (1998) Agonist regulation of human β₂-adrenergic receptor mRNA stability occurs via a specific AU-rich element. J. Biol. Chem. 273, 3223–3229.

6.	Devedjian, J-C, Fargues, M., Denis-Pouxiel, C, Daviaud, D., Prats, H., and Paris, H. (1991) Regulation of the α_2a-adrenergic receptor in HT29 cell line. J. Biol. Chem. 266, 14359–14366.

7.	Ferry, R., Unsworth, C, Artymyshyn, R., and Molinoff, P. (1994) Regulation of mRNA encoding 5-HT2a receptors in P11 cells through a post-translational mechanism requiring activation of protein kinase C. J. Biol. Chem. 269, 31,850–31,857.

8.	Izzo, N., Tulenko, T., and Colucci, W. (1994) Phorbol esters and norepinephrine destabilize α1b-adrenergic receptor mRNA in vascular smooth muscle cells. J. Biol. Chem. 269, 1705–1710.

9.	Lee, N., Earle-Hughes, J., and Frazer, C. (1994) Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA. J. Biol. Chem. 269, 4291–4298.

10.	Mitchusson, K. D., Blaxall, B. C, Pende, A., and Port, J. D. (1998) Agonist-mediated destabilization of human β₁-adrenergic receptor mRNA; role of the 3′ untranslated region. Biochem. Biophys. Res. Commun. 252, 357–362.

11.	Collins, S., Caron, M., and Lefkowitz, R. (1991) Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. Ann. Rev. Physiol. 53, 497–508.

12.	Fitzgerald, L. R., Li, Z., Machida, C. A., Fishman, P. H., and Duman, R. S. (1996) Adrenergic regulation of ICER (inducible cyclic AMP early repressor) and β₁-adrenergic receptor gene expression in C6 glioma cells. J. Neurochem. 67, 490–497.

13.	Hosoda, K., Feussner, G., Rydelek-Fitzgerald, L., Fishman, P., and Duman, R. (1994) Agonist and cyclic AMP-mediated regulation of β₁-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells. J. Neurochem. 63, 1635–1645.

14.	Hadcock, J. R. and Malbon, C. C. (1988) Regulation of β-adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc. Natl. Acad. Sci. USA 85, 8415–8419.

15.	Bohjanen, P., Petryniack, B., June, C., Thompson, C., and Lindsten, T. (1992) AU RNA-binding factors differ in their binding specificity’s and affinities. J. Biol. Chem. 267, 6302–6309.

16.	Malter, J. (1989) Identification of an AUUUA-specific messenger RNA binding protein. Science 246, 664–666.

17.	Vakalopoulou, E., Schaack, J., and Shenk, T. (1991) A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11, 3355–3363.

18.	Xu, N., Chen, Y.-A., and Shyu, A-B. (1997) Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell. Biol. 17, 4611–4621.

19.	Couttet, P., Fromont-Racine, M., Steel, D., Pictet, R., and Grange, T. (1997) Messenger RNA deadenylation precedes decapping in mammalian cells. Proc. Natl. Acad. Sci. USA 94, 5628–5633.

20.	Prokipcak, R., Herrick, D., and Ross, J. (1994) Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J. Biol. Chem. 269, 9261–9269.

21.	Bernstein, P. L., Herrick, D. J., Prokipcak, R. D., and Ross, J. (1992) Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev. 6, 642–654.

22.	Wisdom, R. and Lee, W. (1991) The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5, 232–243.

23.	Port, J. D., Huang, L-Y., and Malbon, C. C. (1992) β-adrenergic agonists that down-regulate receptor mRNA up-regulate a M_r 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs. J. Biol. Chem. 267, 24,103–24,108.

24.	Pende, A., Tremmel, K. D., DeMaria, C. T., Blaxall, B. C., Minobe, W., Sherman, J. A., et al. (1996) Regulation of the mRNA-binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway. J. Biol. Chem. 271, 8493–8501.

25.	Tholanikunnel, B. G., Granneman, J. G., and Malbon, C. C. (1995) The Mr 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J. Biol. Chem. 270, 12,787–12,793.

26.	Tholanikunnel, B. G. and Malbon, C. C. (1997) A 20-nucleotide (A+U)-rich element of the β₂-adrenergic receptor (β₂-AR) mRNA mediates binding to the β₂-AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA. J. Biol. Chem. 272, 11,471–11,478.

27.	Zhang, W., Wagner, B., Ehrenman, K., Schaefer, A., DeMaria, C, Crater, D., et al. (1993) Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13, 7652–7665.

28.	DeMaria, C. and Brewer, G. (1996) AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271, 12,179–12,184.

29.	Blaxall, B. C, Pende, A., Brewer, G., and Port, J. D. (1996) Differential binding of p37AUF1 to beta-adrenergic receptor mRNAs. Mol. Biol. Cell. 7, 300A.

30.	Hamilton, B., Nagy, E., Malter, J., Arrick, B., and Rigby, W. (1993) Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem. 268, 8881–8887.

31.	Kiledjian, M., Novick, K., DeMaria, C. T., Brewer, G, and Xu, Q. (1997) Identification of AUF1/hnRNP-D as a component of the α-globin mRNA stability complex. Mol. Cell. Biol. 17, 4870–4876.

32.	Swanson, M. and Dreyfuss, G (1988) Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol. Cell. Biol. 8, 2237–2241.

33.	Levine, T., Gao, F., King, P., Andrews, L., and Keene, J. C. (1993) Hel-N1: an autoimmune RNA-binding protein with specificity of 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13, 3494–3504.

34.	Ma, W-J., Cheng, S., Campbell, C, Wright, A., and Furneaux, H. (1996) Cloning and characterization of HuR, a ubiquitously expressed elav-like protein. J. Biol. Chem. 271, 8144–8151.

35.	Jain, R. G, Andrews, L. G, McGowan, K. M., Pekala, P. H., and Keene, J. D. (1997) Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol. Cell. Biol. 17, 954–962.

36.	Levy, N. S., Chung, S., Furneaux, H., and Levy, A. P. (1998) Hypoxic stabilization of vasular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273, 6417–6423.

37.	Danner, S. and Lohse, M. J. (1997) Cell type-specific regulation of β₂-adrenoceptor mRNA by agonists. Eur. J. Pharmacol. 331, 73–78.

38.	Nickenig, G and Murphy, T. J. (1996) Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol. Pharmacol. 50, 743–751.

39.	Li, Z., Vaidya, V. A., Alvaro, J. D., Iredale, P. A., Hsu, R., Hoffman, G, et al. (1998) Protein kinase C-mediated down-regulation of β₁-adrenergic receptor gene expression in rat C6 glioma cells. Mol. Pharm. 54, 14–21.

40.	Belasco, J. and Brawerman, G (1993) Control of Messenger RNA Stability. Academic, New York.

41.	Lagnado, C. A., Brown, C. Y., and Goodall, G. J. (1994) AUUUA is not sufficient to promote poly(A) shortening and degradation of a mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14, 7984–7995.

42.	Shyu, A-B., Greenberg, M., and Belasco, J. (1989) The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3, 60–72.

43.	Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475–1489.

44.	Brewer, G. and Ross, J. (1990) Messenger RNA turnover in cell-free extracts. Methods Enzymol. 181, 202–209.

45.	DeMaria, C. T., Sun, Y., Long, L., Wagner, B. J., and Brewer, G. (1997) Structural determinants in AUF1 for high affinity binding to A+U-rich elements. J. Biol. Chem. 272, 27,635–27,643.

46.	Carey J. (1991) Gel retardation. Methods Enzymol. 208, 102–107.

47.	Savante-Bhonsale, S. and Cleveland, D. W. (1992) Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a >20S degradation complex. Genes Dev. 6, 1927–1939.

48.	Ali, N. and Siddiqui, A. (1997) The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. USA 94, 2249–2254.

49.	Chung, S., Eckrich, M., Perrone-Bizzozero, N., Kohn, D. T., and Furneaux, H. (1997) The Elav-like proteins bind to a conserved regulatory element in the 3′-untranslated region of GAP-43 mRNA. J. Biol. Chem. 272, 6593–6598.

Comments (Loading...)

Post comment/View all comments